• レポートコード:MRC2-11QY09101 • 出版社/出版日:QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、111ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療、製薬 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はレチノイン酸受容体ベータのグローバル市場について調査・分析したレポートです。種類別(アリトレチノイン、SBD-073、タミバロテン、タザロテン、その他)市場規模、用途別(代謝性疾患、血液疾患、腫瘍、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別レチノイン酸受容体ベータの競争状況、市場シェア ・世界のレチノイン酸受容体ベータ市場:種類別市場規模 2015年-2020年(アリトレチノイン、SBD-073、タミバロテン、タザロテン、その他) ・世界のレチノイン酸受容体ベータ市場:種類別市場規模予測 2021年-2026年(アリトレチノイン、SBD-073、タミバロテン、タザロテン、その他) ・世界のレチノイン酸受容体ベータ市場:用途別市場規模 2015年-2020年(代謝性疾患、血液疾患、腫瘍、その他) ・世界のレチノイン酸受容体ベータ市場:用途別市場規模予測 2021年-2026年(代謝性疾患、血液疾患、腫瘍、その他) ・北米のレチノイン酸受容体ベータ市場分析:米国、カナダ ・ヨーロッパのレチノイン酸受容体ベータ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのレチノイン酸受容体ベータ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のレチノイン酸受容体ベータ市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのレチノイン酸受容体ベータ市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):3SBio Inc、Lee's Pharmaceutical Holdings Ltd、Phosphagenics Ltd、Promius Pharma LLC、Sol-Gel Technologies Ltd、Valeant Pharmaceuticals International Inc ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Retinoic Acid Receptor Beta Market
The global Retinoic Acid Receptor Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Retinoic Acid Receptor Beta Scope and Market Size
Retinoic Acid Receptor Beta market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retinoic Acid Receptor Beta market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Retinoic Acid Receptor Beta market is segmented into
Alitretinoin
SBD-073
Tamibarotene
Tazarotene
Others
Segment by Application, the Retinoic Acid Receptor Beta market is segmented into
Metabolic Disorders
Hemotological Disorders
Oncology
Others
Regional and Country-level Analysis
The Retinoic Acid Receptor Beta market is analysed and market size information is provided by regions (countries).
The key regions covered in the Retinoic Acid Receptor Beta market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Retinoic Acid Receptor Beta Market Share Analysis
Retinoic Acid Receptor Beta market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Retinoic Acid Receptor Beta business, the date to enter into the Retinoic Acid Receptor Beta market, Retinoic Acid Receptor Beta product introduction, recent developments, etc.
The major vendors covered:
3SBio Inc
Lee’s Pharmaceutical Holdings Ltd
Phosphagenics Ltd
Promius Pharma LLC
Sol-Gel Technologies Ltd
Valeant Pharmaceuticals International Inc
…
1 Study Coverage
1.1 Retinoic Acid Receptor Beta Product Introduction
1.2 Market Segments
1.3 Key Retinoic Acid Receptor Beta Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Retinoic Acid Receptor Beta Market Size Growth Rate by Type
1.4.2 Alitretinoin
1.4.3 SBD-073
1.4.4 Tamibarotene
1.4.5 Tazarotene
1.4.6 Others
1.5 Market by Application
1.5.1 Global Retinoic Acid Receptor Beta Market Size Growth Rate by Application
1.5.2 Metabolic Disorders
1.5.3 Hemotological Disorders
1.5.4 Oncology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Retinoic Acid Receptor Beta Market Size, Estimates and Forecasts
2.1.1 Global Retinoic Acid Receptor Beta Revenue 2015-2026
2.1.2 Global Retinoic Acid Receptor Beta Sales 2015-2026
2.2 Global Retinoic Acid Receptor Beta, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Retinoic Acid Receptor Beta Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Retinoic Acid Receptor Beta Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Retinoic Acid Receptor Beta Competitor Landscape by Players
3.1 Retinoic Acid Receptor Beta Sales by Manufacturers
3.1.1 Retinoic Acid Receptor Beta Sales by Manufacturers (2015-2020)
3.1.2 Retinoic Acid Receptor Beta Sales Market Share by Manufacturers (2015-2020)
3.2 Retinoic Acid Receptor Beta Revenue by Manufacturers
3.2.1 Retinoic Acid Receptor Beta Revenue by Manufacturers (2015-2020)
3.2.2 Retinoic Acid Receptor Beta Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Retinoic Acid Receptor Beta Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Retinoic Acid Receptor Beta Revenue in 2019
3.2.5 Global Retinoic Acid Receptor Beta Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Retinoic Acid Receptor Beta Price by Manufacturers
3.4 Retinoic Acid Receptor Beta Manufacturing Base Distribution, Product Types
3.4.1 Retinoic Acid Receptor Beta Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Retinoic Acid Receptor Beta Product Type
3.4.3 Date of International Manufacturers Enter into Retinoic Acid Receptor Beta Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Retinoic Acid Receptor Beta Market Size by Type (2015-2020)
4.1.1 Global Retinoic Acid Receptor Beta Sales by Type (2015-2020)
4.1.2 Global Retinoic Acid Receptor Beta Revenue by Type (2015-2020)
4.1.3 Retinoic Acid Receptor Beta Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Retinoic Acid Receptor Beta Market Size Forecast by Type (2021-2026)
4.2.1 Global Retinoic Acid Receptor Beta Sales Forecast by Type (2021-2026)
4.2.2 Global Retinoic Acid Receptor Beta Revenue Forecast by Type (2021-2026)
4.2.3 Retinoic Acid Receptor Beta Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Retinoic Acid Receptor Beta Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Retinoic Acid Receptor Beta Market Size by Application (2015-2020)
5.1.1 Global Retinoic Acid Receptor Beta Sales by Application (2015-2020)
5.1.2 Global Retinoic Acid Receptor Beta Revenue by Application (2015-2020)
5.1.3 Retinoic Acid Receptor Beta Price by Application (2015-2020)
5.2 Retinoic Acid Receptor Beta Market Size Forecast by Application (2021-2026)
5.2.1 Global Retinoic Acid Receptor Beta Sales Forecast by Application (2021-2026)
5.2.2 Global Retinoic Acid Receptor Beta Revenue Forecast by Application (2021-2026)
5.2.3 Global Retinoic Acid Receptor Beta Price Forecast by Application (2021-2026)
6 North America
6.1 North America Retinoic Acid Receptor Beta by Country
6.1.1 North America Retinoic Acid Receptor Beta Sales by Country
6.1.2 North America Retinoic Acid Receptor Beta Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Retinoic Acid Receptor Beta Market Facts & Figures by Type
6.3 North America Retinoic Acid Receptor Beta Market Facts & Figures by Application
7 Europe
7.1 Europe Retinoic Acid Receptor Beta by Country
7.1.1 Europe Retinoic Acid Receptor Beta Sales by Country
7.1.2 Europe Retinoic Acid Receptor Beta Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Retinoic Acid Receptor Beta Market Facts & Figures by Type
7.3 Europe Retinoic Acid Receptor Beta Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Retinoic Acid Receptor Beta by Region
8.1.1 Asia Pacific Retinoic Acid Receptor Beta Sales by Region
8.1.2 Asia Pacific Retinoic Acid Receptor Beta Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Retinoic Acid Receptor Beta Market Facts & Figures by Type
8.3 Asia Pacific Retinoic Acid Receptor Beta Market Facts & Figures by Application
9 Latin America
9.1 Latin America Retinoic Acid Receptor Beta by Country
9.1.1 Latin America Retinoic Acid Receptor Beta Sales by Country
9.1.2 Latin America Retinoic Acid Receptor Beta Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Retinoic Acid Receptor Beta Market Facts & Figures by Type
9.3 Central & South America Retinoic Acid Receptor Beta Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Retinoic Acid Receptor Beta by Country
10.1.1 Middle East and Africa Retinoic Acid Receptor Beta Sales by Country
10.1.2 Middle East and Africa Retinoic Acid Receptor Beta Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Retinoic Acid Receptor Beta Market Facts & Figures by Type
10.3 Middle East and Africa Retinoic Acid Receptor Beta Market Facts & Figures by Application
11 Company Profiles
11.1 3SBio Inc
11.1.1 3SBio Inc Corporation Information
11.1.2 3SBio Inc Description and Business Overview
11.1.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc Retinoic Acid Receptor Beta Products Offered
11.1.5 3SBio Inc Related Developments
11.2 Lee’s Pharmaceutical Holdings Ltd
11.2.1 Lee’s Pharmaceutical Holdings Ltd Corporation Information
11.2.2 Lee’s Pharmaceutical Holdings Ltd Description and Business Overview
11.2.3 Lee’s Pharmaceutical Holdings Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Lee’s Pharmaceutical Holdings Ltd Retinoic Acid Receptor Beta Products Offered
11.2.5 Lee’s Pharmaceutical Holdings Ltd Related Developments
11.3 Phosphagenics Ltd
11.3.1 Phosphagenics Ltd Corporation Information
11.3.2 Phosphagenics Ltd Description and Business Overview
11.3.3 Phosphagenics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Phosphagenics Ltd Retinoic Acid Receptor Beta Products Offered
11.3.5 Phosphagenics Ltd Related Developments
11.4 Promius Pharma LLC
11.4.1 Promius Pharma LLC Corporation Information
11.4.2 Promius Pharma LLC Description and Business Overview
11.4.3 Promius Pharma LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Promius Pharma LLC Retinoic Acid Receptor Beta Products Offered
11.4.5 Promius Pharma LLC Related Developments
11.5 Sol-Gel Technologies Ltd
11.5.1 Sol-Gel Technologies Ltd Corporation Information
11.5.2 Sol-Gel Technologies Ltd Description and Business Overview
11.5.3 Sol-Gel Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sol-Gel Technologies Ltd Retinoic Acid Receptor Beta Products Offered
11.5.5 Sol-Gel Technologies Ltd Related Developments
11.6 Valeant Pharmaceuticals International Inc
11.6.1 Valeant Pharmaceuticals International Inc Corporation Information
11.6.2 Valeant Pharmaceuticals International Inc Description and Business Overview
11.6.3 Valeant Pharmaceuticals International Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Beta Products Offered
11.6.5 Valeant Pharmaceuticals International Inc Related Developments
11.1 3SBio Inc
11.1.1 3SBio Inc Corporation Information
11.1.2 3SBio Inc Description and Business Overview
11.1.3 3SBio Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 3SBio Inc Retinoic Acid Receptor Beta Products Offered
11.1.5 3SBio Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Retinoic Acid Receptor Beta Market Estimates and Projections by Region
12.1.1 Global Retinoic Acid Receptor Beta Sales Forecast by Regions 2021-2026
12.1.2 Global Retinoic Acid Receptor Beta Revenue Forecast by Regions 2021-2026
12.2 North America Retinoic Acid Receptor Beta Market Size Forecast (2021-2026)
12.2.1 North America: Retinoic Acid Receptor Beta Sales Forecast (2021-2026)
12.2.2 North America: Retinoic Acid Receptor Beta Revenue Forecast (2021-2026)
12.2.3 North America: Retinoic Acid Receptor Beta Market Size Forecast by Country (2021-2026)
12.3 Europe Retinoic Acid Receptor Beta Market Size Forecast (2021-2026)
12.3.1 Europe: Retinoic Acid Receptor Beta Sales Forecast (2021-2026)
12.3.2 Europe: Retinoic Acid Receptor Beta Revenue Forecast (2021-2026)
12.3.3 Europe: Retinoic Acid Receptor Beta Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Retinoic Acid Receptor Beta Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Retinoic Acid Receptor Beta Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Retinoic Acid Receptor Beta Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Retinoic Acid Receptor Beta Market Size Forecast by Region (2021-2026)
12.5 Latin America Retinoic Acid Receptor Beta Market Size Forecast (2021-2026)
12.5.1 Latin America: Retinoic Acid Receptor Beta Sales Forecast (2021-2026)
12.5.2 Latin America: Retinoic Acid Receptor Beta Revenue Forecast (2021-2026)
12.5.3 Latin America: Retinoic Acid Receptor Beta Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Retinoic Acid Receptor Beta Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Retinoic Acid Receptor Beta Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Retinoic Acid Receptor Beta Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Retinoic Acid Receptor Beta Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Retinoic Acid Receptor Beta Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Retinoic Acid Receptor Beta Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Retinoic Acid Receptor Beta Market Segments
Table 2. Ranking of Global Top Retinoic Acid Receptor Beta Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Retinoic Acid Receptor Beta Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Alitretinoin
Table 5. Major Manufacturers of SBD-073
Table 6. Major Manufacturers of Tamibarotene
Table 7. Major Manufacturers of Tazarotene
Table 8. Major Manufacturers of Others
Table 9. Global Retinoic Acid Receptor Beta Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Retinoic Acid Receptor Beta Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Retinoic Acid Receptor Beta Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Retinoic Acid Receptor Beta Sales Market Share by Regions (2015-2020)
Table 13. Global Retinoic Acid Receptor Beta Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Retinoic Acid Receptor Beta Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Retinoic Acid Receptor Beta Sales Share by Manufacturers (2015-2020)
Table 16. Global Retinoic Acid Receptor Beta Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Retinoic Acid Receptor Beta by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinoic Acid Receptor Beta as of 2019)
Table 18. Retinoic Acid Receptor Beta Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Retinoic Acid Receptor Beta Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Retinoic Acid Receptor Beta Price (2015-2020) (USD/Pcs)
Table 21. Retinoic Acid Receptor Beta Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Retinoic Acid Receptor Beta Product Type
Table 23. Date of International Manufacturers Enter into Retinoic Acid Receptor Beta Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinoic Acid Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 26. Global Retinoic Acid Receptor Beta Sales Share by Type (2015-2020)
Table 27. Global Retinoic Acid Receptor Beta Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Retinoic Acid Receptor Beta Revenue Share by Type (2015-2020)
Table 29. Retinoic Acid Receptor Beta Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Retinoic Acid Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 31. Global Retinoic Acid Receptor Beta Sales Share by Application (2015-2020)
Table 32. North America Retinoic Acid Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 33. North America Retinoic Acid Receptor Beta Sales Market Share by Country (2015-2020)
Table 34. North America Retinoic Acid Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Retinoic Acid Receptor Beta Revenue Market Share by Country (2015-2020)
Table 36. North America Retinoic Acid Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 37. North America Retinoic Acid Receptor Beta Sales Market Share by Type (2015-2020)
Table 38. North America Retinoic Acid Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 39. North America Retinoic Acid Receptor Beta Sales Market Share by Application (2015-2020)
Table 40. Europe Retinoic Acid Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Retinoic Acid Receptor Beta Sales Market Share by Country (2015-2020)
Table 42. Europe Retinoic Acid Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Retinoic Acid Receptor Beta Revenue Market Share by Country (2015-2020)
Table 44. Europe Retinoic Acid Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Retinoic Acid Receptor Beta Sales Market Share by Type (2015-2020)
Table 46. Europe Retinoic Acid Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Retinoic Acid Receptor Beta Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Retinoic Acid Receptor Beta Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Retinoic Acid Receptor Beta Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Retinoic Acid Receptor Beta Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Retinoic Acid Receptor Beta Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Retinoic Acid Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Retinoic Acid Receptor Beta Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Retinoic Acid Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Retinoic Acid Receptor Beta Sales Market Share by Application (2015-2020)
Table 56. Latin America Retinoic Acid Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Retinoic Acid Receptor Beta Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Retinoic Acid Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Retinoic Acid Receptor Beta Revenue Market Share by Country (2015-2020)
Table 60. Latin America Retinoic Acid Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Retinoic Acid Receptor Beta Sales Market Share by Type (2015-2020)
Table 62. Latin America Retinoic Acid Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Retinoic Acid Receptor Beta Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Retinoic Acid Receptor Beta Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Retinoic Acid Receptor Beta Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Retinoic Acid Receptor Beta Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Retinoic Acid Receptor Beta Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Retinoic Acid Receptor Beta Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Retinoic Acid Receptor Beta Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Retinoic Acid Receptor Beta Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Retinoic Acid Receptor Beta Sales Market Share by Application (2015-2020)
Table 72. 3SBio Inc Corporation Information
Table 73. 3SBio Inc Description and Major Businesses
Table 74. 3SBio Inc Retinoic Acid Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. 3SBio Inc Product
Table 76. 3SBio Inc Recent Development
Table 77. Lee's Pharmaceutical Holdings Ltd Corporation Information
Table 78. Lee's Pharmaceutical Holdings Ltd Description and Major Businesses
Table 79. Lee's Pharmaceutical Holdings Ltd Retinoic Acid Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Lee's Pharmaceutical Holdings Ltd Product
Table 81. Lee's Pharmaceutical Holdings Ltd Recent Development
Table 82. Phosphagenics Ltd Corporation Information
Table 83. Phosphagenics Ltd Description and Major Businesses
Table 84. Phosphagenics Ltd Retinoic Acid Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Phosphagenics Ltd Product
Table 86. Phosphagenics Ltd Recent Development
Table 87. Promius Pharma LLC Corporation Information
Table 88. Promius Pharma LLC Description and Major Businesses
Table 89. Promius Pharma LLC Retinoic Acid Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Promius Pharma LLC Product
Table 91. Promius Pharma LLC Recent Development
Table 92. Sol-Gel Technologies Ltd Corporation Information
Table 93. Sol-Gel Technologies Ltd Description and Major Businesses
Table 94. Sol-Gel Technologies Ltd Retinoic Acid Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Sol-Gel Technologies Ltd Product
Table 96. Sol-Gel Technologies Ltd Recent Development
Table 97. Valeant Pharmaceuticals International Inc Corporation Information
Table 98. Valeant Pharmaceuticals International Inc Description and Major Businesses
Table 99. Valeant Pharmaceuticals International Inc Retinoic Acid Receptor Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Valeant Pharmaceuticals International Inc Product
Table 101. Valeant Pharmaceuticals International Inc Recent Development
Table 102. Global Retinoic Acid Receptor Beta Sales Forecast by Regions (2021-2026) (K Pcs)
Table 103. Global Retinoic Acid Receptor Beta Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global Retinoic Acid Receptor Beta Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global Retinoic Acid Receptor Beta Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: Retinoic Acid Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. North America: Retinoic Acid Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: Retinoic Acid Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Europe: Retinoic Acid Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: Retinoic Acid Receptor Beta Sales Forecast by Region (2021-2026) (K Pcs)
Table 111. Asia Pacific: Retinoic Acid Receptor Beta Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: Retinoic Acid Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Latin America: Retinoic Acid Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: Retinoic Acid Receptor Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Middle East and Africa: Retinoic Acid Receptor Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key Retinoic Acid Receptor Beta Players
Table 120. Retinoic Acid Receptor Beta Customers List
Table 121. Retinoic Acid Receptor Beta Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Retinoic Acid Receptor Beta Product Picture
Figure 2. Global Retinoic Acid Receptor Beta Sales Market Share by Type in 2020 & 2026
Figure 3. Alitretinoin Product Picture
Figure 4. SBD-073 Product Picture
Figure 5. Tamibarotene Product Picture
Figure 6. Tazarotene Product Picture
Figure 7. Others Product Picture
Figure 8. Global Retinoic Acid Receptor Beta Sales Market Share by Application in 2020 & 2026
Figure 9. Metabolic Disorders
Figure 10. Hemotological Disorders
Figure 11. Oncology
Figure 12. Others
Figure 13. Retinoic Acid Receptor Beta Report Years Considered
Figure 14. Global Retinoic Acid Receptor Beta Market Size 2015-2026 (US$ Million)
Figure 15. Global Retinoic Acid Receptor Beta Sales 2015-2026 (K Pcs)
Figure 16. Global Retinoic Acid Receptor Beta Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Retinoic Acid Receptor Beta Sales Market Share by Region (2015-2020)
Figure 18. Global Retinoic Acid Receptor Beta Sales Market Share by Region in 2019
Figure 19. Global Retinoic Acid Receptor Beta Revenue Market Share by Region (2015-2020)
Figure 20. Global Retinoic Acid Receptor Beta Revenue Market Share by Region in 2019
Figure 21. Global Retinoic Acid Receptor Beta Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Retinoic Acid Receptor Beta Revenue in 2019
Figure 23. Retinoic Acid Receptor Beta Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Retinoic Acid Receptor Beta Sales Market Share by Type (2015-2020)
Figure 25. Global Retinoic Acid Receptor Beta Sales Market Share by Type in 2019
Figure 26. Global Retinoic Acid Receptor Beta Revenue Market Share by Type (2015-2020)
Figure 27. Global Retinoic Acid Receptor Beta Revenue Market Share by Type in 2019
Figure 28. Global Retinoic Acid Receptor Beta Market Share by Price Range (2015-2020)
Figure 29. Global Retinoic Acid Receptor Beta Sales Market Share by Application (2015-2020)
Figure 30. Global Retinoic Acid Receptor Beta Sales Market Share by Application in 2019
Figure 31. Global Retinoic Acid Receptor Beta Revenue Market Share by Application (2015-2020)
Figure 32. Global Retinoic Acid Receptor Beta Revenue Market Share by Application in 2019
Figure 33. North America Retinoic Acid Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Retinoic Acid Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Retinoic Acid Receptor Beta Sales Market Share by Country in 2019
Figure 36. North America Retinoic Acid Receptor Beta Revenue Market Share by Country in 2019
Figure 37. U.S. Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Retinoic Acid Receptor Beta Market Share by Type in 2019
Figure 42. North America Retinoic Acid Receptor Beta Market Share by Application in 2019
Figure 43. Europe Retinoic Acid Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Retinoic Acid Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Retinoic Acid Receptor Beta Sales Market Share by Country in 2019
Figure 46. Europe Retinoic Acid Receptor Beta Revenue Market Share by Country in 2019
Figure 47. Germany Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Retinoic Acid Receptor Beta Market Share by Type in 2019
Figure 58. Europe Retinoic Acid Receptor Beta Market Share by Application in 2019
Figure 59. Asia Pacific Retinoic Acid Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Retinoic Acid Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Retinoic Acid Receptor Beta Sales Market Share by Region in 2019
Figure 62. Asia Pacific Retinoic Acid Receptor Beta Revenue Market Share by Region in 2019
Figure 63. China Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Retinoic Acid Receptor Beta Market Share by Type in 2019
Figure 86. Asia Pacific Retinoic Acid Receptor Beta Market Share by Application in 2019
Figure 87. Latin America Retinoic Acid Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Retinoic Acid Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Retinoic Acid Receptor Beta Sales Market Share by Country in 2019
Figure 90. Latin America Retinoic Acid Receptor Beta Revenue Market Share by Country in 2019
Figure 91. Mexico Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Retinoic Acid Receptor Beta Market Share by Type in 2019
Figure 98. Latin America Retinoic Acid Receptor Beta Market Share by Application in 2019
Figure 99. Middle East and Africa Retinoic Acid Receptor Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Retinoic Acid Receptor Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Retinoic Acid Receptor Beta Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Retinoic Acid Receptor Beta Revenue Market Share by Country in 2019
Figure 103. Turkey Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Retinoic Acid Receptor Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Retinoic Acid Receptor Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Retinoic Acid Receptor Beta Market Share by Type in 2019
Figure 110. Middle East and Africa Retinoic Acid Receptor Beta Market Share by Application in 2019
Figure 111. North America Retinoic Acid Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Retinoic Acid Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Retinoic Acid Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Retinoic Acid Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Retinoic Acid Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Retinoic Acid Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Retinoic Acid Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Retinoic Acid Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Retinoic Acid Receptor Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Retinoic Acid Receptor Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed